About
History
Director
Organization
Research
All Faculty
Neuroscience
Cardiovascular & Metabolic Diseases
Infectious Disease & Immunology
Cancer
Resource
Administrative
Core facilities
Funding
Events
News
Seminars
Conferences
Careers
Jobs
Education Programs
Links
WebMail
Intranet
Publications
Links
Online Booking
中文
Dr. Kannagi, Reiji
Emeritus Research Fellow
Specialty:
Cancer-associated Glycans
Lymphocyte Homing
Selectins, Siglecs and CD44
Education and Positions:
M.D., Ph.D. Kyoto University
Dr. Kannagi, Reiji 's
Research Highlights
Dr. Kannagi, Reiji 's Lab
Dr. Kannagi, Reiji 's Research Highlights
BGN/TLR4/NF-B Mediates Epigenetic Silencing of Immunosuppressive Siglec Ligands in Colon Cancer Cells
Cells, Feb 09, 2020
SSEA3 and Sialyl Lewis a Glycan Expression Is Controlled by B3GALT5 LTR through Lamin A-NFYA and SIRT1-STAT3 Signaling in Human ES Cells
Cells, Jan 10, 2020
Epigenetic silencing of the synthesis of immunosuppressive Siglec ligand glycans by NF-κB/EZH2/YY1 axis in early-stage colon cancers
Biochimica et Biophysica Acta-Gene Regulatory Mechanisms, Feb 01, 2019
Transcription factors c-Myc and CDX
2
mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial–mesenchymal transition
PNAS, May 15, 2012